Next |
home / stock / rnlx / rnlx message board
Subject | By | Source | When |
---|---|---|---|
Price gaining up | Moeclay | investorshub | 06/26/2023 4:13:12 PM |
$RNLX short squeeze article | Moeclay | investorshub | 06/19/2023 8:13:25 PM |
$RNLX Good news recently, we should start to see this one move | Moeclay | investorshub | 06/10/2023 7:17:06 PM |
short squeeze article | Moeclay | investorshub | 06/08/2023 10:54:56 AM |
Have a look at this | wwind | investorshub | 06/08/2023 7:25:02 AM |
Because I bought when it was at $12. | Moeclay | investorshub | 02/18/2021 7:58:06 PM |
Why? | wwind | investorshub | 02/17/2021 12:41:33 PM |
Disclosure: I'm out | Moeclay | investorshub | 02/16/2021 3:57:39 PM |
With all these new variants, the digital readout | Moeclay | investorshub | 01/25/2021 8:24:37 PM |
Paying close attention to numbers 3, 6, and 8 | Moeclay | investorshub | 01/21/2021 10:39:11 PM |
Hope some testing news comes soon. Executive orders | Moeclay | investorshub | 01/21/2021 9:49:16 PM |
Last couple days have been pretty good for | wwind | investorshub | 01/14/2021 2:37:30 PM |
No word, but I'm hoping they get some | Moeclay | investorshub | 01/12/2021 6:44:36 PM |
thanx... I bought the stock when | wwind | investorshub | 01/12/2021 12:17:36 PM |
With a low volume, undiscovered stock you'll see | Moeclay | investorshub | 01/05/2021 5:49:16 PM |
So--what's with the wild fluctuations in the stock | wwind | investorshub | 01/04/2021 12:49:37 PM |
Someone still tested positive, even after getting the vaccine... | Moeclay | investorshub | 12/31/2020 7:08:41 PM |
We're on the launch pad. Countdown is about | Moeclay | investorshub | 12/26/2020 2:48:15 PM |
Once the vaccines hit the market in a | Moeclay | investorshub | 12/06/2020 1:37:34 AM |
$RNLX is the sleeper Covid testing kit company. | Moeclay | investorshub | 11/28/2020 5:37:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Renalytix AI plc Company Name:
RNLX Stock Symbol:
NASDAQ Market:
LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ:RNLX) (LSE: RENX) announces a registered direct offering of ...
LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary shares at a purchase price equivalent to $0.75 per NASDAQ ADS ($0.375 per common stock share) (£0.0025 each) (the “ Ordinary ...
LONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (Renalytix) announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO (Kidney Disease Improving Global Outcomes) 2024 Clinical Practice Guideline for ...